TGFB1 and nasopharyngeal carcinoma: In fact, out of the four identified miRNAs associated with an increased risk of advanced nasopharyngeal cancer, MiR-449b has the capacity to modify the TGF-β pathway, leading to the development of cisplatin resistance in NPC [196].